MedPath

WILLIAM STOOPS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

10

Active:0
Completed:7

Trial Phases

3 Phases

Early Phase 1:6
Phase 1:1
Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Early Phase 1
6 (60.0%)
Not Applicable
3 (30.0%)
Phase 1
1 (10.0%)

Cocaine and Pentoxifylline (BED IN 47)

Not Applicable
Not yet recruiting
Conditions
Methamphetamine Use Disorder
Interventions
First Posted Date
2025-07-25
Last Posted Date
2025-08-19
Lead Sponsor
William Stoops
Target Recruit Count
30
Registration Number
NCT07086794
Locations
🇺🇸

Psychopharmacology of Addiction Laboratory, Lexington, Kentucky, United States

Behavioral Effects of Drugs (Inpatient): 43 (Opioids, Cocaine, n-Acetylcysteine)

Early Phase 1
Recruiting
Conditions
Cocaine Use Disorder
Opioid Use Disorder
Interventions
First Posted Date
2022-11-09
Last Posted Date
2025-06-11
Lead Sponsor
William Stoops
Target Recruit Count
24
Registration Number
NCT05610072
Locations
🇺🇸

University of Kentucky Laboratory of Human Behavioral Pharmacology, Lexington, Kentucky, United States

🇺🇸

University of Kentucky Department of Behavioral Science, Lexington, Kentucky, United States

Cocaine and Zolmitriptan

Early Phase 1
Completed
Conditions
Cocaine Use Disorder
Interventions
Drug: Placebo oral capsule
First Posted Date
2021-08-24
Last Posted Date
2025-08-05
Lead Sponsor
William Stoops
Target Recruit Count
12
Registration Number
NCT05019430
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

Behavioral Effects of Drugs (Inpatient): 38

Early Phase 1
Terminated
Conditions
Cocaine Use, Unspecified
Interventions
Behavioral: Craving Manipulation
Drug: Placebo
First Posted Date
2019-05-17
Last Posted Date
2024-05-23
Lead Sponsor
William Stoops
Target Recruit Count
5
Registration Number
NCT03954938
Locations
🇺🇸

University of Kentucky Laboratory of Human Behavioral Pharmacology, Lexington, Kentucky, United States

Suvorexant and Cocaine

Early Phase 1
Completed
Conditions
Cocaine Use Disorder
Interventions
Drug: Placebo oral capsule
First Posted Date
2019-05-06
Last Posted Date
2023-02-09
Lead Sponsor
William Stoops
Target Recruit Count
8
Registration Number
NCT03937986
Locations
🇺🇸

University of Kentucky, Lexington, Kentucky, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.